ArticleEpidemiology and infection2016
Quantifying the incidence and cost of acute gastrointestinal illness in Sweden, 2013-2014.
Article in Epidemiology and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Comprehensive Review and Meta-analysis on the Treatment of Acute Gastroenteritis in Children with a Bacillus clausii Preparation (EnterogerminaAdvances in therapy · 2025Pooled it
- Burden of gastrointestinal illness in Sweden-SMS as a tool for collecting self-reported gastrointestinal illness.Epidemiology and infection · 2019Trial
- Self-reported infections in Norway: a study of incidence, doctor visits, antibiotic use, and absence from work.BMC primary care · 2026Article
- Prevalence and Determinants of Acute Gastrointestinal Illness among Irrigation Farmworkers in Gelan Farm Sites, Sheger City, Ethiopia.Environmental health insights · 2026Article
- Multicenter evaluation of the QIAstat-Dx Gastrointestinal Panel 2, a multiplex PCR platform for the diagnosis of acute gastroenteritis.Journal of clinical microbiology · 2025Article
- The epidemiology of acute gastrointestinal illness in Ethiopia, Mozambique, Nigeria, and Tanzania: a population survey.Epidemiology and infection · 2025Article
- Article
- Short- and long-term direct and indirect costs of illness after ostomy creation - a Swedish nationwide registry study.BMC health services research · 2023Observational
- Can foodborne illness estimates from different countries be legitimately compared?: case study of rates in the UK compared with Australia, Canada and USA.BMJ open gastroenterology · 2023Article
- Antibiotics for gastroenteritis in general practice and out-of-hour services in Norway 2006-15.Family practice · 2022Article
- Acute Gastroenteritis Disease Burden in Infants With Medical Risk Conditions in the Netherlands.The Pediatric infectious disease journal · 2021Article
- Determinants and risk factors of gastroenteritis in the general population, a web-based cohort between 2014 and 2017 in France.BMC public health · 2020Article
- Randomized, Placebo-Controlled, Double-Blind and Open-Label Studies in the Treatment and Prevention of Acute Diarrhea WithFrontiers in medicine · 2020Article
- Consultations for gastroenteritis in general practice and out-of-hours services in Norway 2006-15.Family practice · 2019Article
- The burden of gastroenteritis in Switzerland (BUGS) study: a research proposal for a 1-year, prospective cohort study.BMC research notes · 2018Article
- Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden.Applied health economics and health policy · 2018Article
- Article
- High added value of a population-based participatory surveillance system for community acute gastrointestinal, respiratory and influenza-like illnesses in Sweden, 2013-2014 using the web.Epidemiology and infection · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Sweden, acute gastrointestinal illness (AGI) incidence, severity, impact on productivity, related healthcare usage and associated costs are not ascertained. We measured these in 2013-2014 using a population-based cohort reporting weekly. We defined AGI as ⩾3 episodes of loose stools or vomiting/24 h; or loose stools or vomiting with ⩾2 other gastrointestinal symptoms. After each AGI episode, we collected information about perceived severity, healthcare use and absenteeism. We calculated incidence rates, AGI absenteeism and costs comprising direct healthcare costs and productivity loss due to work/school absenteeism. A total of 3241 participants reported 1696 AGI episodes [incidence 360/1000 person-years, 95% confidence interval (CI) 326-395; highest in the <5 years age group]. In the <5 years age group, 31% of episodes were perceived as mild, 61% as moderate and 8% as severe; 9·4% led to primary-care consultations, and 1·4% to hospital admissions. In the ⩾5 years age group, 18% of episodes were perceived as mild, 64% as moderate and 18% as severe; 6·4% led to primary-care consultations, and 1·9% to hospital admissions. AGI caused 8 891 000 days of absenteeism (95% CI 6 009 000-12 780 000). AGI cost €1 005 885 000 (95% CI 754 309 000-1 257 195 000) nationally for the year. In Sweden, a minority of cases perceive AGI as a mild illness. AGI is a burden on the healthcare system and causes productivity loss, with high costs. Countries may consider these estimates when prioritizing health interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.